The launch of the injection faces potential threats, including the Trump administration's proposed cuts to federal funding for HIV prevention efforts.
  • ShoeThrower@lemmy.zipEnglish
    11·
    9 days ago

    In the US it will cost $30,000 per year of treatment, while a generic version could be sold for $40 and still be massively profitable.